Gilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer Pipeline Written By sheeba farhat9 April 2026 4:43 PM ISTBengaluru: Gilead said on Tuesday it would acquire Germany-based Tubulis GmbH for up to USD 5 billion, as it looks to strengthen its cancer drugs...
Pharma Firms Seek 50% Price Hike in Key Cancer Drugs Including Carboplatin, Cisplatin, Approach NPPA: Report Written By Parthika Patel6 April 2026 9:20 PM ISTNew Delhi: Domestic drug manufacturers have sought a 50% increase in prices of key cancer medicines such as carboplatin, cisplatin and oxaliplatin,...
Intas Pharma Barred from Using Cancer Drug Brand BEVATAS Similar to Sun Pharma's BEVETEX Written By Susmita Roy3 April 2026 3:23 PM ISTNew Delhi: In a significant ruling on pharmaceutical trademark infringement, the Delhi High Court in the case of Sun Pharma Laboratories Limited vs...
Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer Studies Written By Parthika Patel28 March 2026 8:37 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited has shared clinical updates on Fibromun and Nidlegy, with key studies failing to meet primary...
Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma Written By sheeba farhat23 March 2026 11:15 AM ISTBengaluru: The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination treatment for adults and adolescents...
Pharma Companies Told to Cut Prices of 17 Duty Exempt Cancer Drugs Written By Susmita Roy13 Feb 2026 8:41 PM ISTNew Delhi: In a follow-up to the customs duty relief on essential medicines, the National Pharmaceutical Pricing Authority (NPPA) has directed...
Brain Cancer Drug Found in Wrong Packaging at Kerala RCC, SHRC Steps In Written By Susmita Roy31 Jan 2026 6:39 PM ISTThiruvananthapuram: A serious lapse in drug labeling at the Regional Cancer Centre (RCC), Thiruvananthapuram, has drawn the attention of the Kerala...
Bristol Myers Approaches SC to Halt Zydus' Biosimilar Nivolumab Sale Written By Parthika Patel30 Jan 2026 7:35 PM ISTNew Delhi: Bristol Myers Squibb has approached the Supreme Court of India, seeking to restrain Zydus Lifesciences from manufacturing and selling its...
India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and Devices Written By Susmita Roy29 Jan 2026 11:15 PM ISTNew Delhi: India's Free Trade Agreement (FTA) with the European Union is being projected as a major breakthrough for healthcare, with expectations of...
Vadodara Researcher's Innovation: Freeze-Dried Technology That Improves Longevity of Cancer Drugs Written By Parthika Patel13 Jan 2026 9:05 PM ISTVadodara: In a major boost for cancer treatment and drug stability, researchers have developed a new freeze-dried formulation that can significantly...
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal Written By sheeba farhat9 Jan 2026 2:59 PM ISTNew Delhi: Merck is in talks to buy cancer drug developer Revolution Medicines in a USD 28 billion to USD 32 billion deal, the Financial Times...
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs Written By Parthika Patel7 Jan 2026 4:37 PM ISTThese products are among the largest oncology biologics expected to lose exclusivity over the next five years.
